These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 731251)

  • 41. Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    de Santiago L; Sánchez-Morla E; Blanco R; Miguel JM; Amo C; Ortiz Del Castillo M; López A; Boquete L
    PLoS One; 2018; 13(4):e0194964. PubMed ID: 29677200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of stimulus orientation on the visual evoked potential in multiple sclerosis.
    Camisa J; Mylin LH; Bodis-Wollner I
    Ann Neurol; 1981 Dec; 10(6):532-9. PubMed ID: 7325602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [VEP in the determination of multiple lesions in the visual system in patients with multiple sclerosis].
    Röder H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Dec; 22(4):234-8. PubMed ID: 1786785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Pulfrich effect in the clinic.
    Heng S; Dutton GN
    Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):801-8. PubMed ID: 21503769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dysfunction of the magnocellular pathway in Alzheimer's disease].
    Jacob B; Hache JC; Pasquier F
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):555-64. PubMed ID: 12072823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual and somatosensory evoked cortical potentials in multiple sclerosis.
    Trojaborg W; Petersen E
    J Neurol Neurosurg Psychiatry; 1979 Apr; 42(4):323-30. PubMed ID: 458479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Apparatus for measuring the difference of retinal latency in the two eyes during the Pulfrich effect. Pulfrich effect].
    Daniele Sargentini A; Neroni M
    Boll Ocul; 1969 Nov; 48(11):859-66. PubMed ID: 5403881
    [No Abstract]   [Full Text] [Related]  

  • 48. [Disorders of reaction to optic signals in multiple sclerosis].
    Lehmann HJ; Hauss K; Jainz M
    Arch Psychiatr Nervenkr (1970); 1972; 216(4):371-8. PubMed ID: 4656949
    [No Abstract]   [Full Text] [Related]  

  • 49. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving test-retest variability of visual-evoked responses in multiple sclerosis: implications for trial design.
    Thomae E; Niklas A; Sebraoui H; Baum P; Wagner A; Then Bergh F
    J Clin Neurophysiol; 2010 Aug; 27(4):270-3. PubMed ID: 20634712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of the Pulfrich phenomenon secondary to pigmentary glaucoma.
    Tong DT; Borsting E; Ridder WH
    Optometry; 2001 Feb; 72(2):86-93. PubMed ID: 11243435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Pulfrich phenomenon in organic and functional conduction disorders of the visual perception tract].
    Remky H
    Fortschr Ophthalmol; 1983; 79(6):539-41. PubMed ID: 6873827
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of interocular delay on disparity-selective v1 neurons: relationship to stereoacuity and the pulfrich effect.
    Read JC; Cumming BG
    J Neurophysiol; 2005 Aug; 94(2):1541-53. PubMed ID: 15788521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in pattern evoked visual potentials in multiple sclerosis in respect to development of illness].
    Koerner E; Ladurner G; Flooh E; Reinhart B; Wolf R; Lechner H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Jun; 13(2):73-6. PubMed ID: 6811242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Steady state VER measurement of visual system latency in normal and multiple sclerosis patients.
    van Brocklin MD; Yolton RL
    J Am Optom Assoc; 1979 Feb; 50(2):203-7. PubMed ID: 458100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern visual evoked potentials in multiple sclerosis.
    Rizzo PA; Amabile G; Parisi L; Pierelli F; Pozzessere G; Morocutti C
    Acta Neurol (Napoli); 1980 Aug; 2(4):270-5. PubMed ID: 7211514
    [No Abstract]   [Full Text] [Related]  

  • 57. Are somatosensory evoked potentials of the tibial nerve the most sensitive test in diagnosing multiple sclerosis?
    Djuric S; Djuric V; Zivkovic M; Milosevic V; Jolic M; Stamenovic J; Djordjevic G; Calixto M
    Neurol India; 2010; 58(4):537-41. PubMed ID: 20739788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
    Blanco R; Pérez-Rico C; Puertas-Muñoz I; Ayuso-Peralta L; Boquete L; Arévalo-Serrano J
    Mult Scler; 2014 Feb; 20(2):183-91. PubMed ID: 23828868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
    Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
    Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.